Induction of innate immunity by IL-2-expressing Salmonella confers protection against lethal infection

Molecular Immunology

Volumn 39, Issue 13, 2003, Pages 763-770

  Al Ramadi, Basel K ^a   Mustafa, Nada ^a   AbouHaidar, Mounir ^a,b   Fernandez Cabezudo, Maria J ^a  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Innate immunity; Interleukin 2; NK cells; NO production; Salmonella

Indexed keywords

INTERLEUKIN 2; MESSENGER RNA; NITRIC OXIDE;

ANIMAL CELL; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CONTROLLED STUDY; CYTOTOXICITY; IMMUNITY; LETHALITY; MOUSE; NONHUMAN; PERITONEAL CAVITY; PERITONEUM EXUDATE; PRIORITY JOURNAL; PROTECTION; PROVOCATION TEST; SALMONELLA; SALMONELLOSIS; TIME; UPREGULATION;

BACTERIA (MICROORGANISMS); SALMONELLA;

EID: 0037374623     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-5890(03)00005-1     Document Type: Article

References (36)

1. Alam M.S., Akaike T., Okamoto S., Kubota T., Yoshitake J., Sawa T., Miyamoto Y., Tamura F., Maeda H. Role of nitric oxide in host defense in murine salmonellosis as a function of its antibacterial and antiapoptotic activities. Infect. Immun. 70:2002;3130-3142.
2. al-Ramadi B.K., Brodkin M.A., Mosser D.M., Eisenstein T.K. Immunosuppression induced by attenuated Salmonella: evidence for mediation by macrophage precursors. J. Immunol. 146:1991;2737-2746.
3. al-Ramadi B.K., Meissler J.J. Jr., Huang D., Eisenstein T.K. Immunosuppression induced by nitric oxide and its inhibition by interleukin-4. Eur. J. Immunol. 22:1992;2249-2254.
4. al-Ramadi B.K., Jelonek M.T., Boyd L.F., Margulies D.H., Bothwell A.L.M. Lack of strict correlation of functional sensitization with the apparent affinity of MHC/peptide complexes for the T-cell receptor. J. Immunol. 155:1995;662-673.
5. al-Ramadi B.K., Al-Dhaheri M.H., Mustafa N., AbouHaidar M., Xu D., Liew F.Y., Lukic M.L., Fernandez-Cabezudo M.J. Influence of vector-encoded cytokines on anti-Salmonella immunity: divergent effects of interkeukin-2 and tumor necrosis factor alpha. Infect. Immun. 69:2001;3980-3988.
6. al-Ramadi B.K., Adeghate E., Mustafa N., Ponery A.S., Fernandez-Cabezudo M.J. Cytokine expression by attenuated intracellular bacteria regulates the immune response to infections: the Salmonella model. Mol. Immunol. 38:2002;931-940.
7. Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y.-J., Pulendran B., Palucka K. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18:2000;767-811.
8. Basse P., Whiteside T., Chambers W., Herberman R. Therapeutic activity of NK cells against tumors. Int. Rev. Immunol. 20:2001;439-501.
9. Biron C.A., Young H.A., Kasaian M.T. Interleukin-2-induced proliferation of murine natural killer cells in vivo. J. Exp. Med. 171:1990;173-188.
10. Boise L.H., Collins C.M. Salmonella-induced cell death: apoptosis, necrosis, or programmed cell death? Trends Micrbiol. 9:2001;64-67.
11. Chatfield S.N., Strahan K., Pickard D., Charles I.G., Hormaeche C.E., Dougan G. Evaluation of Salmonella typhimurium strains harbouring defined mutations in htrA and aroA in the murine salmonellosis model. Microb. Pathog. 12:1992;145-151.
12. Cifone M.G. Interleukin-2 activated rat natural killer cells express inducible nitric oxide synthase that contributes to cytotoxic function and interferon-γ production. Blood. 93:1999;3876-3884.
13. de Jong R., Altare F., Haagen I.A., Elferink D.G., Boer T., van Breda Vriesman P.J., Kabel P.J., Draaisma J.M., van Dissel J.T., Kroon F.P., Casanova J.L., Ottenhoff T.H. Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients. Science. 280:1998;1435-1438.
14. Diefenbach A., Schindler H., Donhauser N., Lorenz E., Laskay T., MacMicking J., Rollinghoff M., Gresser I., Bogdan C. Type 1 interferon (IFN-α/β) and type 2 nitric oxide synthase regulate the innate immune response to a protozoan parasite. Immunity. 8:1998;77-87.
15. Diefenbach A., Schindler H., Rollinghoff M., Yokoyama W.M., Bogdan C. Requirement for type 2 NO synthase for IL-12 signaling in innate immunity. Science. 282:1999;951-955.
16. Diefenbach A., Jamieson A.M., Liu S.D., Shastri N., Raulet D.H. Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages. Nat. Immunol. 1:2000;119-126.
17. Eisenstein T.K. Implications of Salmonella-induced nitric oxide (NO) for host defense and vaccines: NO, an antimicrobial, antitumor, immunosuppressive, and immunoregulatory molecule. Microbes Infect. 3:2001;1223-1231.
18. Flexner C., Hugin A., Moss B. Prevention of vaccinia virus infection in immunodeficient mice by vector-directed IL-2 expression. Nature. 330:1987;259-262.
19. Jouanguy E., Doffinger R., Dupuis S., Pallier A., Altare F., Casanova J.L. IL-12 and IFN-γ in host defense against mycobacterial and Salmonella in mice and men. Curr. Opin. Immunol. 11:1999;346-351.
20. Karupiah G., Blanden R.V., Ramshaw I.A. Interferon gamma is involved in the recovery of athymic nude mice from recombinant vaccinia virus/interleukin-2 infection. J. Exp. Med. 172:1990a;1495-1503.
21. Karupiah G., Coupar B.E.H., Andrew M.E., Boyle D.B., Phillips S.M., Mullbacher A., Blanden R.V., Ramshaw I.A. Elevated natural killer cell responses in mice infected with recombinant vaccinia virus encoding murine IL-2. J. Immunol. 144:1990b;290-298.
22. Laskay T., Diefenbach A., Rollinghoff M., Solbach W. Early parasite containment is decisive for resistance to Leishmania major infection. Eur. J. Immunol. 25:1995;2220-2227.
23. Martin-Fontecha A., Assarsson E., Carbone E., Karre K., Ljunggren H.-G. Triggering of murine NK cells by CD40 and CD86 (B7-2). J. Immunol. 162:1999;5910-5916.
24. Matzinger P. The JAM test: a simple assay for DNA fragmentation and cell death. J. Immunol. Methods. 145:1991;185-192.
25. Medzhitov R., Janeway C. Jr. Innate immune recognition: mechanisms and pathways. Immunol. Rev. 173:2000;89-97.
26. Mittrucker H.-W., Kaufmann S.H.E. Immune response to infection with Salmonella typhimurium in mice. J. Leukoc. Biol. 67:2000;457-463.
27. Poltorak A., He X., Smirnova L., Liu M.Y., Huffel C.V., Du X., Birdwell D., Alejos E., Silva M., Galanos C., Freudenberg M., Ricciardi-Castagnoli P., Layton B., Beutler B. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science. 282:1998;2085-2088.
28. Pulendran B., Palucka K., Banchereau J. Sensing pathogens and tuning immune responses. Science. 293:2001;253-256.
29. Richter-Dahlfors A., Buchan A.M.J., Finlay B.B. Murine salmonellosis studied by confocal microscopy: Salmonella typhimurium resides intracellularly inside macrophages and exerts a cytotoxic effect on phagocytes in vivo. J. Exp. Med. 186:1997;569-580.
30. Schafer R., Eisenstein T.K. Natural killer cells mediate protection induced by a Salmonella aroA mutant. Infect. Immun. 60:1992;791-797.
31. Scharton-Kersten T., Afonso L.C., Wysocka M., Trinchieri G., Scott P. IL-12 is required for natural killer cell activation and subsequent T-helper 1 cell development in experimental leishmaniasis. J. Immunol. 154:1995;5320-5330.
32. Schwacha M.G., Meissler J.J. Jr., Eisenstein T.K. Salmonella typhimurium infection in mice induces nitric oxide-mediated immunosuppression through a natural killer cell-dependent pathway. Infect. Immun. 66:1998;5862-5866.
33. Shiloh M.U., Nathan C.F. Reactive nitrogen intermediates and the pathogenesis of Salmonella and mycobacteria. Curr. Opin. Microbiol. 3:2000;35-42.
34. Sztein M.B., Wasserman S.S., Tacket C.O., Edelman R., Hone D., Lindberg A.A., Levine M.M. Cytokine production patterns and lymphoproliferative responses in volunteers orally immunized with attenuated vaccine strains of Salmonella typhi. J. Infect. Dis. 170:1994;1508-1517.
35. Tacket C.O., Sztein M.B., Wasserman S.S., Losonsky G., Kotloff K.L., Wyant T.L., Nataro J.P., Edelman R., Perry J., Bedford P., Brown D., Chatfield S., Dougan G., Levine M.M. Phase 2 clinical trial of attenuated Salmonella enterica serovar Typhi oral live vector vaccine CVD 908-htrA in US volunteers. Infect. Immun. 68:2000;1196-1201.
36. Xu D., McSorley S.J., Tetley L., Chatfield S., Dougan G., Chan W.L., Satoskar A., David J.R., Liew F.Y. Protective effect on Leishmania major infection of migration inhibitory factor, TNF-α, and IFN-γ administered orally via attenuated Salmonella typhimurium. J. Immunol. 160:1998;1285-1289.